Hybrid Graphene Oxide Can Capture and Identify Rare Cell Selectively
Cancer is known for more than three thousand years, but till in 21st century, it causes 1 in 8 deaths worldwide.
Recent report demonstarted that aptamer conjugated theranostic graphene oxide based assay has exciting potential for improving cancer diagnosis by detecting CTC from infected blood.
The reported new material can have enormous potential for real life applications, once it is optimized properly in clinical settings
